SCHEMBL14965376

SCHEMBL14965376

O=[N+]([O-])c1cn2c(n1)OCCN(CC1CCNCC1)CC2

nearest known ligand 0.35

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.35
CACNA2D1 P54289 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNB1 Q02641 1/20 0.34
KCNH2 Q12809 4/20 0.32
SIGMAR1 Q99720 1/20 0.32
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
KCNJ1 P48048 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14965891 0.89 CHRM1 (0.36) CHRM1KCNH2ALDH1A1MAPT
SCHEMBL14965604 0.84 THRB (0.34) CHRM1KCNH2SIGMAR1ALDH1A1MAPT
SCHEMBL14965838 0.81 CHRM1 (0.34) CHRM1KCNH2
SCHEMBL14966146 0.81 CHRM1 (0.36) CHRM1KCNH2ALDH1A1
SCHEMBL14966080 0.79 ALDH1A1 (0.39) KCNH2ALDH1A1MAPT
SCHEMBL14965946 0.77 CYP1A2 (0.46) SIGMAR1
SCHEMBL14965567 0.77 CHRM1 (0.36) CHRM1KCNH2ALDH1A1MAPT
SCHEMBL1046316 0.77 CHRM1 (0.40) CHRM1KCNH2ALDH1A1MAPT
Hydrochloric Acid SCHEMBL14965816 0.76 CHRM1 (0.36) CHRM1KCNH2ALDH1A1MAPT
SCHEMBL14965717 0.76 CHRM1 (0.35) CHRM1KCNH2ALDH1A1MAPTKCNJ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013072903-A1 NITROIMIDAZOXADIAZOCINE COMPOUNDS ITHEMBA PHARMACEUTICALS (PROPRIETARY) LIMITED (ZA) 2013-05-23 WO claimed
WO-2013072903-A1 NITROIMIDAZOXADIAZOCINE COMPOUNDS ITHEMBA PHARMACEUTICALS (PROPRIETARY) LIMITED (ZA) 2013-05-23 WO disclosed
WO-2013072903-A1 NITROIMIDAZOXADIAZOCINE COMPOUNDS ITHEMBA PHARMACEUTICALS (PROPRIETARY) LIMITED (ZA) 2013-05-23 WO disclosed